Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Snape MD, et al. Among authors: john tm. JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. JAMA. 2008. PMID: 18182599 Clinical Trial.
Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T, Voysey M, Yu LM, McCarthy N, Baudin M, Richard P, Fiquet A, Kitchin N, Pollard AJ. John T, et al. Vaccine. 2015 Aug 26;33(36):4579-85. doi: 10.1016/j.vaccine.2015.06.105. Epub 2015 Jul 10. Vaccine. 2015. PMID: 26165918 Clinical Trial.
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A. Waddington C, et al. Among authors: john t. Health Technol Assess. 2010 Oct;14(46):1-130. doi: 10.3310/hta14460-01. Health Technol Assess. 2010. PMID: 20923610 Clinical Trial.
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston PE, Allen RJ, Okike I, Ladhani S, Sheasby E, Hoschler K, Andrews N, Waight P, Collinson AC, Heath PT, Finn A, Faust SN, Snape MD, Miller E, Pollard AJ. Waddington CS, et al. Among authors: john t. BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649. BMJ. 2010. PMID: 20508026 Free PMC article. Clinical Trial.
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.
Snape MD, Kelly DF, Lewis S, Banner C, Kibwana L, Moore CE, Diggle L, John T, Yu LM, Borrow R, Borkowski A, Nau C, Pollard AJ. Snape MD, et al. Among authors: john t. BMJ. 2008 Jun 28;336(7659):1487-91. doi: 10.1136/bmj.39563.545255.AE. Epub 2008 Jun 5. BMJ. 2008. PMID: 18535032 Free PMC article.
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
Snape MD, Saroey P, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Wang H, Toneatto D, Dull PM, Pollard AJ. Snape MD, et al. Among authors: john tm. CMAJ. 2013 Oct 15;185(15):E715-24. doi: 10.1503/cmaj.130257. Epub 2013 Sep 23. CMAJ. 2013. PMID: 24062178 Free PMC article. Clinical Trial.
Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.
Snape MD, Philip J, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Kittel C, Toneatto D, Dull PM, Pollard AJ. Snape MD, et al. Among authors: john tm. Pediatr Infect Dis J. 2013 Oct;32(10):1116-21. doi: 10.1097/INF.0b013e31829cfff2. Pediatr Infect Dis J. 2013. PMID: 23958808 Clinical Trial.
B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. Perrett KP, et al. Among authors: john tm. J Immunol. 2012 Sep 1;189(5):2673-81. doi: 10.4049/jimmunol.1200451. Epub 2012 Aug 1. J Immunol. 2012. PMID: 22855707
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
Khatami A, Snape MD, Wysocki J, John TM, Westcar S, Mesaros N, Peddiraju K, Boutriau D, Yu LM, Pollard AJ. Khatami A, et al. Among authors: john tm. Pediatr Infect Dis J. 2012 Oct;31(10):1069-73. doi: 10.1097/INF.0b013e318262528c. Pediatr Infect Dis J. 2012. PMID: 22673139 Clinical Trial.
Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.
Metz JA, Hanieh S, Pradhan R, Joshi A, Shakya D, Shrestha L, Shrestha A, Upadhyay B, Kelly SC, John TM, Maharjan BD, Yu LM, Omar O, Borrow R, Findlow J, Kelly DF, Thorson SM, Adhikari N, Murdoch DR, Pollard AJ. Metz JA, et al. Among authors: john tm. Pediatr Infect Dis J. 2012 Apr;31(4):e66-72. doi: 10.1097/INF.0b013e31824a9c37. Pediatr Infect Dis J. 2012. PMID: 22418662 Clinical Trial.
93 results
Jump to page
Feedback